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Lymph node lymphocytes from guinea pigs sensitized 
with the hapten homogenized in Freund's complete ad-
juvant or pretreated with cyclophosphamide shortly be-
fore an epicutaneous sensitization are capable of r e-
sponding in vitro to a larger set of antigenic preparations 
than the lymphocytes from only epicutaneously sensi-
tized animals. 
This may be due to a formation of a larger set of 
antigenic determinants when the hapten was homoge-
nized in Freund's complete adjuvant or to a formation of 
a larger repertoire of lymphocytes capable of recogniz-
ing these determinants as it might be the result of pre-
treatment with cyclophosphamide. These procedures 
may also change the proportion of responding cells in 
the lymphocyte suspensions. 
The experimental model of guinea pig contact sensitivity has 
been widely used both for research of the mechanism of allergic 
eczema and for investigation of potential allergenicity of various 
substances. For this purpose animals were sensitized either by 
an epicutaneous application of the hapten or by intradermal 
injections of the hapten homogenized in Freund's complete 
adjuvant [1]. However, some experimental results have shown 
that there exist substantial differences in contact sensitivity 
induced by these 2 sensitising methods. These differences be-
come manifest both in vivo and in vitro. 
The main in vivo difference consists in the intensity of the 
eliciting skin reaction and in the composition of the cellular 
infiltrate. It has been shown that contact sensitivity skin reac-
tions in guinea pigs sensitized by the epicutaneous route are 
less erythematous and less indurated but contain more baso-
phils than the skin reaction in animals sensitized with the 
antigen in Freund's complete adjuvant [2]. 
In a previous paper it has been demonstrated that several 
antigenic preparations such as dinitrophenyl (DNP)-coated 
nonviable lymphocytes (DNCB-Ly) or DNP-modified macro-
phages (DNP-M<t>) are capable of stimulating in vitro lympho-
cytes from guinea pigs sensitized with dinitrofluorobenzene 
(DNFB) in Freund's complete adjuvant (FCA). Enhanced 
DNA-synthesis in vitro was also achieved by a short pulse of 
sensitized lymphocytes with dinitrobenzenesulfonic acid sodium 
salt (DNBS03Na) and to a lesser extent also by a direct addition 
of this hapten or hapten-autologous protein conjugate to the 
culture [3]. 
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Abbreviations: 
CY: Cytimun, a cyclophosphamide preparation 
DMSO: dimethylsulfoxid 
DNCB: 2,4 dini trochlorobenzene 
DNCB-Ly: dinitrophenyl (DNP)-coated rion viable lymphocytes 
DNFB: 2,4 dinitrofluorobenzene 
DNBS03Na: 2,4 dinitrobenzene sulfonic acid sodium salt 
DNP-M¢: DNP-modified macrophages 
FCA: Freund's complete adjuvant 
S03-Ly: DNBS03Na pulsed viable lymphocytes 
In vitro stimulation of lymphocytes from guinea pigs sensi-
t ized by an epicutaneous application of the hapten dinitro-
chlorobenzene (DNCB) was, however, achieved only when 
DNP-modified macrophages were used as antigen [ 4]. All the 
other ant igenic preparations which were successful in stimulat-
ing lymphocytes from animals sensitized with the help of FCA 
failed to induce an enhanced DNA-synthesis in lymphocytes 
from animals sensitized by the epicutaneous method [5]. 
In the present paper it is shown that lymphocytes from 
guinea pigs sensitized either intradermally with the hapten 
homogenized in Freund's complete adjuvant or pretreated with 
cyclophosphamide shortly before sensitization are capable of 
responding in vitro to a larger set of specific antigenic prepa-
rations than lymphocytes from animals sensitized epicuta-
neously. On the basis of the literature and of our experiments 
attempt is made to clarify the mechanism of these resul ts. 
MATERIALS AND METHODS 
Animals 
Inbred strain 13 guinea pigs of either sex bred at the Institute for 
Biochemical Research, Fiillinsdorf, Switzerland, weighing 350-450 gm, 
were used. They were fed on pellet diet supplemented ad libitum with 
water containing vitamin C. 
Immunization. Guinea pigs were sensit ized either by epicutaneous 
application of 25 J.Ll of a 50% solu t ion of DNCB (2,4-dinitrochloroben-
zene, Merck, Darmstadt, FRG) in acetone on the nape of the neck and 
on the ears or by 5 intradermal injec tions of totally 500 Jig DNFB (2,4-
dinitrofluorobenzene, Fluka AG, Buchs SG, Switzerland) homogenized 
in 0.5 ml FCA (Freund's complete adjuvant, Difco Lab. , Detroit, Mich. , 
USA) into the footpads and the nap~ of the neck. 
CY (Cyclophosphamide derivative Cytimun C 682, Asta-Werke AG, 
Brackwede, FRG) was given intraperitoneally (250 mg/kg) 3 days 
before the sensitizing procedure. 
The spli t adjuvant technique consisted. of a simul taneous epicuta-
neous application of DNCB and intradermal injections of FCA. A 
separate group of animals was injected i.d. with FCA only. 
Hru·vesting of lymphoid cells. A single cell suspension was prepared 
from dmining lymph nodes. The cells were teased from the nodes with 
specially constructed forks and ftl tered through nylon stocking mesh. 
T - and B-cells were separated on 50 ml syringes filled with nylon 
wool (Leuko-Pak, Fenwal Lab. , Deerfield, Ill. , USA). The nonadherent 
T-ceL!s were collected by eluting the column with RPMI 1640 medium 
containing 10% fetal calf serum (FCS) after incubation of the lympho-
cytes for 30 min at 37°C. B-cells were recovered by repeatedly com-
pressing the nylon wool with forceps and rinsing the column with 
RPMI 1640 medium containing 5% FCS. Contaminating adherent T-
cells were removed by rosetting them with papain- treated rabbit eryth-
rocytes and centrifuging them through a Ficoll-Paque (Phl!rmacia Fine 
Chemicals AB, Uppsala, Sweden) cushion (density 1.085 g/ml, 15 min, 
1500 Xg ). 
Antigenic preparations. SO"-Ly were prepared by pulsing sensit ized 
lymphocytes for 2 hr with 500 J.Lg/ ml DNBSO"Na (2,4-dinitrobenzene-
sulphonic ac id sodium salt, Eastman Kodak, Rochester, N.Y., USA). 
DNCB-Ly (7 x 104/ mi) were obtained by incubating blood lympho-
cytes, purified on a Ficoll-Paque cushion, in a 10% DNCB solution in 
' DMSO (dimethylsulfoxide, Schuchardt, Hohenbrunn, FRG) for 30 min 
at 37°C. DNP-Mcf> (5 X 10''/ ml) were prepared by incubating irradiated 
(3300 r) peritoneal exudate cells, harvested 3- 5 days after an i.p. 
injection of 30 mlligh t pru·affin oil (Drakeol 6-VR White, P~nna, Butler, 
Penn. USA) , in a DNFB solut ion (10 J.Lg/ ml) in Hanks' BSS (GIBCO 
Bio-Cult , Glasgow, Scotland) for 30 min at 37°C. 
In. vitro stimulation. 5 X 10'' lymphocytes were cultured in 1 ml 
RPMI 1640 medium conta ining 5% heat- inactivated fetal calf serum, 5 
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fig /ml 5-0uorocytosine (Hoffmann-La Roche & Co., Basle, Switzer-
land), 50 /~g/ml gentamicin (Schering & Co., Kenilworth, N.J.) and 10- '• 
M 2-mercaptoethanol (Sigma Chemical Co., St. Louis, Mo.) for 120 hr 
at 37°C in a humidified atmosphere of 5% C02 and 95% air. The culture 
was pulsed for the last 18 hr with 1 1-iCi of "H-thymidine (TRA 120, 
spec. act. 5 Ci/mmol, The Radiochemical Centre, Amersham, England) 
per tube (12 X 75 mm, round-bottom plastic tubes, Flacon, Oxnard, 
Calif.) and DNA synthesis was determined by precipitating TCA-insol-
uble material on glass fiber ftlters (Whatman Inc., Clifton, N.J.) and by 
counting in a liquid scintillation spectrometer. 
RESULTS 
In table I it is shown that lymphocytes from guinea pigs 
sensitized with DNFB in FCA responded to a short pulse with 
the cross-reacting hapten DNBS0:1 Na (group 2) as well as to 
a continuous stimulation with either DNP-coated nonviable 
syngeneic blood lymphocytes (DNCB-Ly) (group 4) or with 
DNP-modified macrophages (DNP-M<t>) (group 6) by an in-
creased in vitro DNA-synthesis. DNP-modified macrophages 
were the most efficient stimulators. On the other hand, lym-
phocytes from animals sensitized epicutaneously without the 
help of FCA responded only to DNP-modified macrophages 
(group 5) whereas a short pulse with DNBS0:1 Na or use of 
DNP-coated nonviable lymphocytes did not elicit any in vitro 
response. 
Addition of 50% lymph node lymphocytes from DNCB epi-
cutaneously sensitized animals to lymphocytes from guinea pigs 
sensitized with the hapten homogenized in FCA a nd stimulated 
in vitro with DNCB-Ly (group 7) did not suppress the in vitro 
response of the latter. 
From the results presented in Table II it is evident, that only 
lymphocytes from guinea pigs sensitized intradermally with 
DNFB homogenized in FCA were capable of responding in 
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vitro to DNP-coated lymphocytes (group 2). Lymphocytes from 
guinea pigs sensitized by a s imultaneous application of FCA 
intradermally a nd DNCB epicutaneously (split adjuvant tech-
nique) were unable to respond in vitro to this antigenic prepa-
ration (group 3). Moreover, a co-cu lture of lymphocytes from 
animals sensitized with FCA, i.d., with lymphocytes from guinea 
pigs sensitized epicutaneously with DNCB did not render the 
latter responsive to the mentioned antigenic stimulation (group 
4). 
In order to find out whether the unresponsiveness of lym-
phocytes from DNCB, e.c., sensitized a nimals to a short pulse 
with the hapten (DNBSO:J Na) is due to lack of normal mac-
rophages (macrophage help) these cells were added to the 
cul ture after the pulse with the hapten. As a control the same 
number of hapten modified macrophages (5 X 105) or a combi-
nation of 103 DNP-M<j> with 4 X 10'' normal macrophages were 
used as stimulators. The results in Table III demonstrate that 
the modification of the macrophages by the hapten has to occur 
prior to their addition to t he lymphocyte culture (group 3) . A 
simple addition of normal macro phages to a culture of DNBS03 
Na pulsed lymphocytes from DNCB e.c . sensitized guinea pigs 
did not elicit any in vitro response (group 2). 
Finally, it is shown, that elimination of B-cells from the 
lymphocyte suspension from DNCB e.c. sensitized animals 
(Table IV) did not render the remaining T-cells responsive to 
the stimulation with an antigenic preparation otherwise inef-
fective in unseparated lymphocyte suspensions (DNP-coated 
lymphocytes). However, pretreatment of guinea pigs with cy-
clophosphamide shortly before sensitization induced in these 
animals a population of lymphocytes capable of responding in 
vitro to the mentioned a ntigenic preparation. Both unseparated 
and T-lymphocytes were equally responsive whereas B-cells 
remained unresponsive in spite of the CY-treatment. 
TABLE I. In vitro DNA-synthesis of lymphocytes from guinea pigs sensitized either epicutan.eously with DNCB or intradennally with DNFB 
homogenized in FCA 
Group Sensitization No. of In uilro challenge Baseline Antigen S.l. animals cpm cpm 
DNCB e.c. 8 DNBSO,.Na 500 flg/ml 3882 ± 1207 4358 ± 954 1.4 ± 0.4 
2 h pulse 
2 DNFB/FCA i.d. 7 " 1821 ± 350 24998 ± 5100 13.7 ± 6.9 
3 DNCB e.c. 16 DNCB-Ly 7 x 10' 3440 ± 311 5100 ± 593 1.6 ± 0.3 
4 DNFB/ FCA i.d. 18 " 1460 ± 196 17082 ± 1995 11 .5 ± 7.3 
5 DNCB e.c. 24 DNP-Mq, 5 x 10'' 1846 ± 279 28933 ± 5762 24.6 ± 6.8 
6 DNFB/ FCA i.d. 12 " 2641 ± 612 71307 ± 8341 27.4 ± 13.4 
7 DNFB/FCA i.d.-Ly + 50%· 6 DNCB-Ly 7 x 10'1 986 ± 82 10352 ± 950 10.5 ± 3.5 
DNCB e.c.-Ly 
Lymph node lymphocytes from guinea pigs sensitized either e.c. with DNCB (groups 1, 3 and 5) or i.d. with DNFB in FCA (groups 2, 4 and 6) 
were pulsed for 2 hr with DNBSOaNa (groups 1 and 2) before the 120 hr culture or stimulated during the whole cu lture time with DNP-coupled 
nonviable lymphocytes (groups 3 and 4) . In groups 5 and 6 DNP-modified macrophages were used as stimulators. In group 7 the same set up as 
in group 4 was used but 2.5 x 10'' lymph node lymphocytes from DNCB e.c. sensitized guinea pigs were added at the beginning of the cul ture. 
Non-DNBSO:~N a-treated viable lymphocytes or nonviable unconjugated lymphocytes or normal macrophages served as controls. Results ru·e 
expressed as mean q)m ±standard error and as stimulation indices (S.l.). 
TABLE 11. Effect of Ft·eun.d's complete adjuvant (FCA) on in vitro DNA synthesis of lymphocytes from DNCB-sensitized guinea. pigs 
Group · Sensitization No. of Co-Ly DNCB- Ly an irrials cpm cpm S.I. 
DNCB e.c. 16 3440 ± 311 5100 ± 593 1.6 ± 0.3 
2 DNFB/ FCA i.d. 10 1460 ± 196 39420 ± 3991 27.4 ± 4.3 
homogenized 
3 DNCB e.c. 10 766 ± 106 1759±414 2.3 ± 0.4 
FCA i.d. 
4 LNLy DNCB e.c. 8 2979 ± 930 4056 ± 1122 1.7 ± 0.2 
LNLy FCA i.d. 
. Lymph node lymphocytes (5 X 10" /ml RPMI 1640) from guinea pigs sensitized either with DNCB e. c. (group 1) or with DNFB homogenized 
m FCA (group 2) were cultured with 7 X 104 ONCE-conjugated nonviable lymphocytes (DNCB-Ly) or with the same number of control (DMSO-
treat,ed) lymphocytes (Co-Ly). In group 3 animals were simultaneously sensitized with DNCB e.c. and FCA i.d . In the last group (group 4) 2.5 
X 10·• lymphocytes from DNCB e.c. sensitized animals were mixed with equal numbers of lymphocytes from FCA i.d. sensitized guinea pigs and 
cultured as above. Results are expressed as mean cpm ±standard error and as stimulation indices (SI). 
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Baseline An Ligen S.I. cpm cpm 
3882 ± 1207 4385 ± 954 1.4 ± 0.4 
2860 ± 361 3231 ± 551 1.3 ± 0.3 
1846 ± 279 28933 ± 5762 24.6 ± 6.8 
1221 ± 180 7884 ± 2824 6.5 ± 2.4 
Lymph node lymphocytes from DNCB e.c. sensitized guinea pigs were pulsed for 2 hr with 500 /lg/ ml DNBSOaNa and 5 x IO" cells treated 
(SO:sLY) or nontreated (NLy) were cultured with (group 2) or without (group 1) addition of 5 X 10'' normal macrophages (NMcp). In group 3 
lymphocytes were not pulsed with DNBSOaN~, but 5 X 10'' normal (NMct>) or DNP-modified (DNP-mcp ) macrophages were added to the culture. 
In the group 4 DNP-Mct> (103) + NMcf> (4 X 10 ) were used. Results were expressed as in Table II. 



























2341 ± 207 
3211 ± 623 
1428 ± 187 
841 ± 225 
4431 ± 1981 
4341 ± 1431 
DNCB-Ly 
cpm 
3558 ± 409 
51697 ± 7488 
314 1 ± 521 
10176 ± 3926 
5317 ± 2039 
3473 ± 724 
S. I. 
1.5 ± 0.2 
16.1 ± 3.6 
2.2 ± 0.4 
12.1 ± 5.1 
1.2 ± 0.2 
0.8 ± 0.1 
Lvmph node lymphocytes from guinea pigs sensitized epicutaneously with dinitrochlorobenzene (DNCB) a nd eithe r pretreated 3 days before 
sen~itization with c_vclophosphamide (CY) or sensitized on ly(-) were separated int o T- and B-cells as described in ··Material and Methods." To 
5 x 10:, cells in I ml RPM! I G40 were added 7 X 10·' DNCB-conjugat ed nonviable l.vmphocytes (IJNCB-Ly) or an equal number of control 
(DMSO-t reated) ce lls (Co-Ly). Hesults a re expressed as mean cpm ±standard er ror and as stimu lation indices (S]). 
Lymph node lymphocytes were usually harvested 10-14 days 
after sensitizing procedure but the stimulation indices of unsep-
arated lymphocytes from CY-treated guinea pigs were about 
the same magnitude (14.3 ± 4.2) when cells were harvested 7 to 
10 days later (20 to 24 days after CY-treatment). 
DISCUSSION 
The results in this study indicate that there exists a substan-
tial difference between contact sensitivity induced in guinea 
pigs by the application of the hapten epicutaneously without or 
intradermally with the help of adjuvant. Two antigenic prepa-
rations, namely a short pulse of sensitized lymphocytes with 
the hapten and a stimulation with DNP-coated nonviable blood 
lymphocytes, are unable to induce a positive response in lym-
phocytes from DNCB-epicutaneously sensitized guinea pigs in 
the in vitro DNA-synthesis assay. DNFB-conjugated guinea 
pig skin extracts also failed in this respect [5]. 
In other species such as in man or in the mouse a positive 
response was, however, achieved (6, 8, 9, 10, 11, 12). 
Lymphocytes from guinea pigs exhibited an enhanced in 
vitro synthesis when (a) animals were sensitized intradermally 
with the hapten homogenized in FCA; (b) epicutaneously sen-
sitized animals were pretreated with cyclophosphamide shortly 
before sensitization; (c) hapten modified macrophages were 
used. 
It is known that contact sensitivity is a hypersensitivity 
directed against a set of antigens induced in in vivo conjugation 
of one and the same hapten to various autologous proteins 
[13]. If in vitro prepared conjugates are used for elicitation of 
.in vivo reactions, these reactions are always of lower intensity 
or do not occur at all. 
Generally the effect of adjuvants on the immune response is 
a very complex one and affects both the antigen-reactive and 
the auxiliary cells as well as the function of the antigens [14]. 
The numbers of macrophages and T-cells increases, their cir-
culation becomes enhanced and their surface markers (!a-an-
tigen, Fc-receptor) are changed. Furthermore, the dissemina-
tion of the antigen and its uptake by macrophages is also 
changed. 
The following considerations may help to explain the mech-
anism of the effect of FCA in our experiments. 
Lymphocytes obtained from guinea pigs sen itized by the 
split adjuvant method responded to a smaller set of antigenic 
preparations than lymphocytes from animals sensitized with 
the hapten homogenized in FCA. 
Co-cultures of lymphocytes from FCA-sensitized guinea pigs 
with lymphocytes from animals sensitized epicutaneously with 
the hapten did not enlarge the set of antigenic preparations to 
which the latter were able to respond in vitro. 
Both these results made improbable a nonspecific activation 
of antigen reactive and/or auxiliary cells by FCA as the mech-
an ism of the FCA effect in our system. It appears more probable 
that in our system FCA reacts directly with the hapten thus 
forming a larger set of antigenic. determinants. Under these 
condit ions a larger repertoire of DNP-specific lymphocytes is 
activated which consequently are capable of reacting in. vitro 
with a larger set of antigenic preparations. 
The haptenization of macrophages leads to formation of new 
epitopes which are capable of stimulating lymphocytes from 
DNCB epicutaneously sensitized animals. This may be due 
either to a larger set of determinants formed on macrophages 
or to their closer similari ty to determinants formed in vivo by 
the epicutaneous application of the hapten. An add ition of 
nonhaptenized macrophages to lymphocytes from epicuta-
neously sensitized animals pulsed with the hapten, did not 
effectuate enhanced DNA-synthesis.lt is suggested that by the 
short pulse with the hapten mainly T-cells are haptenized. For 
a significant in vitro stimulation of sensitized lymphocytes less 
than 103 hapten modified macrophages are required providing 
that a sufficien t number of normal macrophages are pi·esent 
(macrophage help) (Blomberg and Polak, manuscript in prep-
aration) . Lymph node lymphocyte suspension contains about 
5% macrophages (in our experiments about 2-4 x 10''). This 
number would, when modified by the hapten, induce a signifi-
cant increase in t he DNA-synthe is in vitro. This was not, 
however, the case in our experiments. It is suggested that a 
sJ1ort pulse with hapten did not induce hapten modified mac-
rophages with corresponding determinants to which antigen 
reactive lymphocytes induced by an epicutaneous sensitization 
would respond. Thi indicates that the in vitro responsiveness 
is dependent mainly on processing and presentation of the 
hapten by macrophages and to a lesser extent on macrophages 
help. 
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The positive results obtained in humans [8, 9] and rabbits [7] 
with DNCB-Ly suggest, however, that the reacting repertoire 
may considerably vary between different species. 
The notion that contact sensitivity is a T-cell phenomenon 
was further confirmed by our results. An increased in vitro 
DNA-synthesis of lymphocytes from CY-pretreated animals 
was confined to this lymphocyte subpopulation. Elimination of 
B-cells which are suggested to be suppressive in guinea pigs 
delayed hypersensitivity [16] did not render T-cells responsive 
to DNCB-Ly preparation. This indicates that the in vitro 
unresponsiveness of lymphocytes from epicutaneously sensi-
tized guinea pigs is not mediated by B-suppressor cells. 
To explain the effect of cyclophosphamide pretreatment is 
more difficult. It is known that application of CY shortly before 
sensitizing procedure enhances the resulting degree of contact 
sensitivity [15]. It is assumed that this is due to elimination of 
suppressor cells . Therefore, the in vitro proliferative response 
of lymphocytes from CY -pretreated animals may be explained 
by the absence of suppressor cells inhibiting the proliferation of 
memory cells. However, several arguments contradict the as-
sumption , that the incapability of lymphocytes from epicuta-
neously sensitized animals of responding in vitro to a large set 
of antigenic preparations is mediated by suppressor cells. At 
the time when lymphocytes are harvested for DNA-synthesis 
assay i.e. 17 to 24 days after CY-application, suppressor cells 
are already regenerated and fully active [15]. 
On the other hand, elimination of suppressor cells by CY-
treatment shortly before an epicutaneous challenge did not 
enhance the intensity of skin reaction [17]. The same treatment 
3 days before cell harvest did not increase the in vitro prolif-
erative response to an antigenic stimulation. The stimulation 
indices in this experiment where 6.6 ± 4.4 compared to 8.0 ± 
4.1 in lymphocytes from sensitized animals not pretreated with 
cyclophosphamide. In this experiment DNP-M<t> were used. 
Moreover, addition of lymphocytes from DNCB epicuta-
neously sensitized guinea pigs did not suppress the enhanced 
DNA-synthesis of cells from animals sensitized with DNFB in 
FCA (Table II). Finally, lymphocytes from epicutaneously sen-
sitized animals can be stimulated in vitro by DNP-modified 
macrophages. These results made improbable that suppressor 
cells are responsible for the failure of lymphocytes from DNCB 
epicutaneously sensitized guinea pigs to respond in vitro to 
some antigenic preparations. 
It might be that the CY -treatment changed the overall reac-
tivity of the lymphocytes during their regeneration. However, 
the proliferative response of nonstimulated cells (baseline cpm) 
was not different in CY -treated and non treated animals. Fur-
thermore, the in vitro stimulation of lymphocytes from CY-
pretreated epicutaneously sensitized guinea pigs remained un-
changed even when the cells were harvested more than 3 weeks 
after CY -application. 
One may imagine that during the lymphocyte regeneration 
the diversity of the repertoire of lymphocytes was altered. 
During, this process of generation of diversity, lymphocytes 
capable of recognizing some self-determinants might be formed . 
This newly formed repertoire might include also lymphocytes 
capable of ,recognizing antigenic determinants formed by the 
reaction of hapten with these determinants. 
Another possibility is that various lymphocyte subpopula-
tions regenerate after CY -treatment to a different degree. Thus, 
the cell suspensions from CY-pretreated guinea pigs used for 
the DNA-synthesis assay may contain a higher ratio of antigen 
reactive cells than suspensions from animals sensitized without 
CY-pretreatment. Two factors may participate in this effect. 
(1) Antigenic stimulus in animals, where the lymphoid organs 
are depleted of lymphocytes might lead to a more potent clonal 
proliferation and thus to a relatively higher representation of 
the antigenic specific cells. Since antigen-reactive cells of con-
tact sensitivity are cyclophosphamide-resistant the prolifera-
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tion of these cells may be favored by the elimination of CY _ 
sensitive lymphocytes. (2) Elimination of suppressor cells at the 
time of sensitization results in an enhanced formation of specific 
memory and effectors cells [15]. 
By these processes the subliminal in vitro response of lym-
phocytes from guinea pigs sensitized epicutaneously with 
DNCB to minor determinants becomes measurable. 
Three factors seem to be decisive for eliciting an enhanced in 
vitro DNA-synthesis: (1) The size of the set of antigens 
formed during sensitization. (2) The size of the repertoire of 
lymphocytes capable of recognizing these antigens. (3) The 
frequency of specific memory cells present in the lymphocyte 
suspensions. 
The practical meaning of this study is that the use of FCA 
for predictive a llergenicity testing in guinea pigs detects larger 
sensitizing potentials than those active when the substances are 
applied epicutaneously. The results obtained with the help of 
adjuvants may therefore to some extent exaggerate the aller-
genicity risks connected with materials used only epicuta-
neously. However, under certain pathological circumstances on 
adjuvant-like effect may occur even during epicutaneous appli-
cation. 
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